On 11/05/2025, SUN PHARMACEUTICAL recalled LISDEXAMFETAMINE DIMESYLATE 70 MG due to Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability station (25°C, 60%RH) for Lisdexamfetamine dimesylate capsules. The U.S. Food and Drug Administration (FDA) has issued a Class II Recall of the affected medications.

More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.

The detailed information of the recalled product is listed below:

Recalled Drug: LISDEXAMFETAMINE DIMESYLATE 70 MG
NDC Number: 57664005288
Lot Number(s): AD48712, AD50898
Expiration Date(s): 04/30/2026, 05/31/2026

What you should do:

• Do not continue to use LISDEXAMFETAMINE DIMESYLATE 70 MG if it has been recalled
• Check your prescription label to see if you have any LISDEXAMFETAMINE DIMESYLATE in the affected lot numbers and expiration dates.
• If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting www.fda.gov/medwatch/report.htm or calling 1-800-FDA-0178.

On 11/05/2025, SUN PHARMACEUTICAL recalled LISDEXAMFETAMINE DIMESYLATE 50 MG due to Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability station (25°C, 60%RH) for Lisdexamfetamine dimesylate capsules. The U.S. Food and Drug Administration (FDA) has issued a Class II Recall of the affected medications.

More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.

The detailed information of the recalled product is listed below:

Recalled Drug: LISDEXAMFETAMINE DIMESYLATE 50 MG
NDC Number: 57664005088
Lot Number(s): AD48710, AD50895
Expiration Date(s): 04/30/2026, 05/31/2026

What you should do:

• Do not continue to use LISDEXAMFETAMINE DIMESYLATE 50 MG if it has been recalled
• Check your prescription label to see if you have any LISDEXAMFETAMINE DIMESYLATE in the affected lot numbers and expiration dates.
• If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting www.fda.gov/medwatch/report.htm or calling 1-800-FDA-0178.

On 11/05/2025, BRECKENRIDGE recalled DULOXETINE HCL 60 MG due to CGMP Deviations: N-nitroso-duloxetine impurity above the safety assessment limit of 12.5ppm. The U.S. Food and Drug Administration (FDA) has issued a Class II Recall of the affected medications.

More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.

The detailed information of the recalled product is listed below:

Recalled Drug: DULOXETINE HCL 60 MG
NDC Number: 51991074890, 51991074810
Lot Number(s): 240721C, 230286C
Expiration Date(s): 02/28/2027, 02/28/2026

What you should do:

• Do not continue to use DULOXETINE HCL 60 MG if it has been recalled
• Check your prescription label to see if you have any DULOXETINE HCL in the affected lot numbers and expiration dates.
• If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting www.fda.gov/medwatch/report.htm or calling 1-800-FDA-0178.

On 11/05/2025, TEVA USA recalled PRAZOSIN HCL 1 MG due to CGMP Deviations-Test results for N-nitroso Prazosin impurity C that are above the Carcinogenic Potency Categorization Approach (CPCA) acceptable intake limit for the above specified lots. The U.S. Food and Drug Administration (FDA) has issued a Class II Recall of the affected medications.

More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.

The detailed information of the recalled product is listed below:

Recalled Drug: PRAZOSIN HCL 1 MG
NDC Number: 00093406701, 00093406710
Lot Number(s): 3010544A, 3010545A, 3010567A, 3010590A, 3010601A, 3010602A, 3010603A, 3010652A, 3010670A, 3010671A, 3010678A, 3010700A, 3010701A, 3010440A, 3010672A
Expiration Date(s): 10/2025, 10/2025, 12/2025, 02/2026, 03/2026, 03/2026, 03/2026, 07/2026, 07/2026, 07/2026, 08/2026, 08/2026, 08/2026, 12/2025, 07/2026

What you should do:

• Do not continue to use PRAZOSIN HCL 1 MG if it has been recalled
• Check your prescription label to see if you have any PRAZOSIN HCL in the affected lot numbers and expiration dates.
• If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting www.fda.gov/medwatch/report.htm or calling 1-800-FDA-0178.

On 11/05/2025, TEVA USA recalled PRAZOSIN HCL 2 MG due to CGMP Deviations-Test results for N-nitroso Prazosin impurity C that are above the Carcinogenic Potency Categorization Approach (CPCA) acceptable intake limit for the above specified lots. The U.S. Food and Drug Administration (FDA) has issued a Class II Recall of the affected medications.

More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.

The detailed information of the recalled product is listed below:

Recalled Drug: PRAZOSIN HCL 2 MG
NDC Number: 00093406801, 00093406810
Lot Number(s): 3010398A, 3010399A, 3010400A, 3010401A, 3010353A, 3010439A, 3010388A, 3010526A, 3010527A, 3010591A, 3010343A, 3010352A, 3010468A, 3010469A, 3010461A, 3010629A, 3010653A, 3010654A, 3010679A, 3010702A, 3010547A, 3010402A, 3010593A, 3010610A
Expiration Date(s): 12/2025, 12/2025, 12/2025, 12/2025, 12/2025, 01/2026, 01/2026, 03/2026, 03/2026, 07/2026, 10/2025, 11/2025, 02/2026, 02/2026, 02/2026, 09/2026, 01/2027, 02/2027, 02/2027, 02/2027, 04/2026, 02/2028, 07/2026, 09/2026

What you should do:

• Do not continue to use PRAZOSIN HCL 2 MG if it has been recalled
• Check your prescription label to see if you have any PRAZOSIN HCL in the affected lot numbers and expiration dates. 
• If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting www.fda.gov/medwatch/report.htm or calling 1-800-FDA-0178.

On 11/05/2025, TEVA USA recalled PRAZOSIN HCL 5 MG due to CGMP Deviations-Test results for N-nitroso Prazosin impurity C that are above the Carcinogenic Potency Categorization Approach (CPCA) acceptable intake limit for the above specified lots. The U.S. Food and Drug Administration (FDA) has issued a Class II Recall of the affected medications.

More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.

The detailed information of the recalled product is listed below:

Recalled Drug: PRAZOSIN HCL 5 MG
NDC Number: 00093406901, 00093406952, 00093406905
Lot Number(s): 3010403A, 3010385A, 3010404A, 3010405A, 3010510A, 3010528A, 3010354A, 3010592A, 3010605A, 3010611A, 3010612A, 3010655A, 3010703A, 3010430A, 3010613A, 3010406A
Expiration Date(s): 02/2026, 02/2026, 02/2026, 03/2026, 03/2026, 03/2026, 03/2026, 08/2026, 08/2026, 08/2026, 08/2026, 02/2027, 02/2027, 11/2025, 08/2026, 02/2026

What you should do:

• Do not continue to use PRAZOSIN HCL 5 MG if it has been recalled
• Check your prescription label to see if you have any PRAZOSIN HCL in the affected lot numbers and expiration dates.
• If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting www.fda.gov/medwatch/report.htm or calling 1-800-FDA-0178.

On 10/15/2025, ACCORD HEALTHCARE recalled LEVOTHYROXINE SODIUM 88 MCG due to Subpotent: During long term stability testing of Levothyroxine Sodium Tablets USP for 88 mcg, the assay content was observed below the approved specification range. The U.S. Food and Drug Administration (FDA) has issued a Class II Recall of the affected medications.

More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.

The detailed information of the recalled product is listed below:

Recalled Drug: LEVOTHYROXINE SODIUM 88 MCG
NDC Number: 16729045015
Lot Number(s): D2300045
Expiration Date(s): 12/31/2025

What you should do:

• Do not continue to use LEVOTHYROXINE SODIUM 88 MCG if it has been recalled
• Check your prescription label to see if you have any LEVOTHYROXINE SODIUM in the affected lot numbers and expiration dates.
• If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting www.fda.gov/medwatch/report.htm or calling 1-800-FDA-0178.

On 10/08/2025, APOTEX CORP. recalled KETOROLAC TROMETHAMINE 0.5 % due to Lack of Assurance of Sterility; atypical weight loss due to improper bottle sealing leading to potential sterility concerns. The U.S. Food and Drug Administration (FDA) has issued a Class II Recall of the affected medications.

More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.

The detailed information of the recalled product is listed below:

Recalled Drug: KETOROLAC TROMETHAMINE 0.5 %
NDC Number: 60505100301
Lot Number(s): VA0444, VA4608 and TZ7016
Expiration Date(s): 01/2026, 01/2026 and 12/2025

What you should do:

• Do not continue to use KETOROLAC TROMETHAMINE 0.5 % if it has been recalled
• Check your prescription label to see if you have any KETOROLAC TROMETHAMINE in the affected lot numbers and expiration dates.
• If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting www.fda.gov/medwatch/report.htm or calling 1-800-FDA-0178.

On 09/24/2025, ASCEND LABORATORIES LLC recalled ARIPIPRAZOLE 10 MG due to superpotent drug. The U.S. Food and Drug Administration (FDA) has issued a Class II Recall of the affected medications.

More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.

The detailed information of the recalled product is listed below:

Recalled Drug: ARIPIPRAZOLE 10 MG
NDC Number: 67877043203
Lot Number(s): 24144162
Expiration Date(s): 09/2027

What you should do:

• Do not continue to use ARIPIPRAZOLE 10 MG if it has been recalled
• Check your prescription label to see if you have any ARIPIPRAZOLE in the affected lot numbers and expiration dates.
• If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting www.fda.gov/medwatch/report.htm or calling 1-800-FDA-0178.

On 09/24/2025, UNICHEM PHARMA recalled CYCLOBENZAPRINE HCL 10 MG due to Labeling: Label Mix Up; Bottles of Meloxicam USP, 7.5mg, 90-count tablets (yellow in color), were labeled as Cyclobenzaprine Hydrochloride Tablets USP, 10 mg 90-count tablets (blue in color). The U.S. Food and Drug Administration (FDA) has issued a Class I Recall of the affected medications.

More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.

The detailed information of the recalled product is listed below:

Recalled Drug: CYCLOBENZAPRINE HCL 10 MG
NDC Number: 29300041519
Lot Number(s): GMML24026A
Expiration Date(s): 09/30/2027

What you should do:

• Do not continue to use CYCLOBENZAPRINE HCL 10 MG if it has been recalled
• Check your prescription label to see if you have any CYCLOBENZAPRINE HCL in the affected lot numbers and expiration dates.
• If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting www.fda.gov/medwatch/report.htm or calling 1-800-FDA-0178.

On 08/20/2025, MERCK & CO INC recalled BELSOMRA 10 MG due to Failed Dissolution Specifications: potential for delayed dissolution of the dose after administration which may result in delayed release of the drug, delaying onset of sleep. The U.S. Food and Drug Administration (FDA) has issued a Class II Recall of the affected medications.

More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.

The detailed information of the recalled product is listed below:

Recalled Drug: BELSOMRA 10 MG
NDC Number: 00006003330 and 00006003310
Lot Number(s): 2090019 and 2123744
Expiration Date(s): 04/30/2027

What you should do:

• Do not continue to use BELSOMRA 10 MG if it has been recalled
• Check your prescription label to see if you have any BELSOMRA in the affected lot numbers and expiration dates.
• If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to

On 08/13/2025, CARDINAL HEALTH recalled XOLAIR 75MG/0.5ML due to CGMP Deviations – Product was exposed to temperatures outside the product’s labeled storage requirements. The U.S. Food and Drug Administration (FDA) has issued a Class II Recall of the affected medications.

More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.

The detailed information of the recalled product is listed below:

Recalled Drug: XOLAIR 75MG/0.5ML
NDC Number: 50242021455
Lot Number(s): 3630004
Expiration Date(s): 10/31/2025

What you should do:

• Do not continue to use XOLAIR 75MG/0.5ML if it has been recalled
• Check your prescription label to see if you have any XOLAIR in the affected lot numbers and expiration dates.
• If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting www.fda.gov/medwatch/report.htm or calling 1-800-FDA-0178.

On 08/06/2025, NOSTRUM LABORATORIES recalled SUCRALFATE 1 G due to CGMP Deviations: The recalling firm filed for Chapter 11 in September 2024. As a result, it cannot monitor the quality program and hence cannot assure that products meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess, rendering the products adulterated. The U.S. Food and Drug Administration (FDA) has issued a Class II Recall of the affected medications.

More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.

The detailed information of the recalled product is listed below:

Recalled Drug: SUCRALFATE 1 G
NDC Number: 29033000305
Lot Number(s): All lots
Expiration Date(s): All expiration dates

What you should do:

• Do not continue to use SUCRALFATE 1 G if it has been recalled
• Check your prescription label to see if you have any SUCRALFATE in the affected lot numbers and expiration dates.
• If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting www.fda.gov/medwatch/report.htm or calling 1-800-FDA-0178.

On 08/13/2025, SUN PHARMACEUTICAL recalled SPIRONOLACTONE 25 MG due to the Presence of foreign substance: identified as aluminum. The U.S. Food and Drug Administration (FDA) has issued a Class II Recall of the affected medications.

More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.

The detailed information of the recalled product is listed below:

Recalled Drug: SPIRONOLACTONE 25 MG
NDC Number: 53489014301
Lot Number(s): P3314
Expiration Date(s): 11/30/2026

What you should do:

• Do not continue to use SPIRONOLACTONE 25 MG if it has been recalled
• Check your prescription label to see if you have any SPIRONOLACTONE in the affected lot numbers and expiration dates.
• If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting www.fda.gov/medwatch/report.htm or calling 1-800-FDA-0178.

On 08/13/2025, ALEMBIC PHARMACEUTICALS recalled DOXEPIN HCL 10 MG due to CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity above the proposed interim limit. The U.S. Food and Drug Administration (FDA) has issued a Class II Recall of the affected medications.

More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.

The detailed information of the recalled product is listed below:

Recalled Drug: DOXEPIN HCL 10 MG
NDC Number: 62332063731
Lot Number(s): 2305015142
Expiration Date(s): 09/30/2025

What you should do:

• Do not continue to use DOXEPIN HCL 10 MG if it has been recalled
• Check your prescription label to see if you have any DOXEPIN HCL in the affected lot numbers and expiration dates.
• If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting www.fda.gov/medwatch/report.htm or calling 1-800-FDA-0178.

On 08/06/2025, STRIDES PHARMA recalled CINACALCET HCL 90 MG due to Failed Dissolution Specifications. The U.S. Food and Drug Administration (FDA) has issued a Class II Recall of the affected medications.

More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.

The detailed information of the recalled product is listed below:

Recalled Drug: CINACALCET HCL 90 MG
NDC Number: 64380088504
Lot Number(s): 7715893A
Expiration Date(s): 12/31/2027

What you should do:

• Do not continue to use CINACALCET HCL 90 MG if it has been recalled
• Check your prescription label to see if you have any CINACALCET HCL in the affected lot numbers and expiration dates.
• If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting www.fda.gov/medwatch/report.htm or calling 1-800-FDA-0178.

On 07/23/2025, ASCEND LABORATORIES recalled RIZATRIPTAN 10 MG due to CGMP Deviations: detection of N-nitroso-dimethyl-rizatriptan impurity, above the FDA recommended acceptable intake limit. The U.S. Food and Drug Administration (FDA) has issued a Class II Recall of the affected medications.

More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.

The detailed information of the recalled product is listed below:

Recalled Drug: RIZATRIPTAN 10 MG
NDC Number: 67877026218
Lot Number(s): 22143653, 22143675, 22144528, 22144977, 23140257, 23140999, 23141900, 23142118, 23142120, 23142123, 23144563, 23144565, 24142623, 24142624, 24142626, 24143469
Expiration Date(s): July 2025, September 2025, November 2025, December 2025, Feb.
2026, May 2026, November 2026, May 2027, Jun 2027

What you should do:

• Do not continue to use RIZATRIPTAN 10 MG if it has been recalled
• Check your prescription label to see if you have any RIZATRIPTAN in the affected lot numbers and expiration dates.
• If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting www.fda.gov/medwatch/report.htm or calling 1-800-FDA-0178.

On 07/23/2025 ASCEND LABORATORIES recalled RIZATRIPTAN 5 MG due to CGMP Deviations: detection of N-nitroso-dimethyl-rizatriptan impurity, above the FDA recommended acceptable intake limit. The U.S. Food and Drug Administration (FDA) has issued a Class II Recall of the affected medications.

More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.

The detailed information of the recalled product is listed below:

Recalled Drug: RIZATRIPTAN 5 MG
NDC Number: 67877026118
Lot Number(s): 23142117, 23142119, 23142122 and 24142625
Expiration Date(s): May 2026 and Jun 2027

What you should do:

• Do not continue to use RIZATRIPTAN 5 MG if it has been recalled
• Check your prescription label to see if you have any RIZATRIPTAN in the affected lot numbers and expiration dates.
• If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting www.fda.gov/medwatch/report.htm or calling 1-800-FDA-0178.

On 07/23/2025, SUN PHARMACEUTICAL recalled LISDEXAMFETAMINE DIMESYLATE 60 MG due to Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 9 month long term stability station (25¿C, 60%RH). The U.S. Food and Drug Administration (FDA) has issued a Class II Recall of the affected medications.

More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.

The detailed information of the recalled product is listed below:

Recalled Drug: LISDEXAMFETAMINE DIMESYLATE 60 MG
NDC Number: 57664005188
Lot Number(s): AD42648
Expiration Date(s): 02/28/2026

What you should do:

• Do not continue to use LISDEXAMFETAMINE DIMESYLATE 60 MG if it has been recalled
• Check your prescription label to see if you have any LISDEXAMFETAMINE DIMESYLATE in the affected lot numbers and expiration dates.
• If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting www.fda.gov/medwatch/report.htm or calling 1-800-FDA-0178.

On 07/23/2025, ACCORD HEALTHCARE recalled LEVOTHYROXINE SODIUM 50 MCG due to Subpotent Drug: Assay below the approved specification. The U.S. Food and Drug Administration (FDA) has issued a Class II Recall of the affected medications.

More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.

The detailed information of the recalled product is listed below:

Recalled Drug: LEVOTHYROXINE SODIUM 50 MCG
NDC Number: 16729044815
Lot Number(s): D2300087
Expiration Date(s): 12/31/2025

What you should do:

• Do not continue to use LEVOTHYROXINE SODIUM 50 MCG if it has been recalled
• Check your prescription label to see if you have any LEVOTHYROXINE SODIUM in the affected lot numbers and expiration dates.
• If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting www.fda.gov/medwatch/report.htm or calling 1-800-FDA-0178.

On 07/23/2025, ACCORD HEALTHCARE recalled LEVOTHYROXINE SODIUM 25 MCG due to Subpotent Drug: Assay below the approved specification. The U.S. Food and Drug Administration (FDA) has issued a Class II Recall of the affected medications.

More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.

The detailed information of the recalled product is listed below:

Recalled Drug: LEVOTHYROXINE SODIUM 25 MCG
NDC Number: 16729044717
Lot Number(s): D2400679
Expiration Date(s): 02/28/2026

What you should do:

• Do not continue to use LEVOTHYROXINE SODIUM 25 MCG if it has been recalled
• Check your prescription label to see if you have any LEVOTHYROXINE SODIUM in the affected lot numbers and expiration dates.
• If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting www.fda.gov/medwatch/report.htm or calling 1-800-FDA-0178.

On 07/23/2025, ACCORD HEALTHCARE recalled LEVOTHYROXINE SODIUM 25 MCG due to Subpotent Drug: Assay below the approved specification. The U.S. Food and Drug Administration (FDA) has issued a Class II Recall of the affected medications.

More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.

The detailed information of the recalled product is listed below:

Recalled Drug: LEVOTHYROXINE SODIUM 25 MCG
NDC Number: 16729044715
Lot Number(s): D2300325, D2400536
Expiration Date(s): 01/31/2026, 02/28/2026

What you should do:

• Do not continue to use LEVOTHYROXINE SODIUM 25 MCG if it has been recalled
• Check your prescription label to see if you have any LEVOTHYROXINE SODIUM in the affected lot numbers and expiration dates.
• If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting www.fda.gov/medwatch/report.htm or calling 1-800-FDA-0178.

On 07/23/2025, ACCORD HEALTHCARE recalled LEVOTHYROXINE SODIUM 175 MCG due to Subpotent Drug: Assay below the approved specification. The U.S. Food and Drug Administration (FDA) has issued a Class II Recall of the affected medications.

More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.

The detailed information of the recalled product is listed below:

Recalled Drug: LEVOTHYROXINE SODIUM 175 MCG
NDC Number: 16729045617
Lot Number(s): D2300042
Expiration Date(s): 12/31/2025

What you should do:

• Do not continue to use LEVOTHYROXINE SODIUM 175 MCG if it has been recalled
• Check your prescription label to see if you have any LEVOTHYROXINE SODIUM in the affected lot numbers and expiration dates.
• If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting www.fda.gov/medwatch/report.htm or calling 1-800-FDA-0178.

On 07/23/2025, ACCORD HEALTHCARE recalled LEVOTHYROXINE SODIUM 150 MCG due to Subpotent Drug: Assay below the approved specification. The U.S. Food and Drug Administration (FDA) has issued a Class II Recall of the affected medications.

More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.

The detailed information of the recalled product is listed below:

Recalled Drug: LEVOTHYROXINE SODIUM 150 MCG
NDC Number: 16729045517
Lot Number(s): D2300076
Expiration Date(s): 12/31/2025

What you should do:

• Do not continue to use LEVOTHYROXINE SODIUM 150 MCG if it has been recalled
• Check your prescription label to see if you have any LEVOTHYROXINE SODIUM in the affected lot numbers and expiration dates.
• If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting www.fda.gov/medwatch/report.htm or calling 1-800-FDA-0178.

On 07/23/2025, ACCORD HEALTHCARE recalled LEVOTHYROXINE SODIUM 112 MCG due to Subpotent Drug: Assay below the approved specification. The U.S. Food and Drug Administration (FDA) has issued a Class II Recall of the affected medications.

More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.

The detailed information of the recalled product is listed below:

Recalled Drug: LEVOTHYROXINE SODIUM 112 MCG
NDC Number: 16729045217
Lot Number(s): D2300104
Expiration Date(s): 12/31/2025

What you should do:

• Do not continue to use LEVOTHYROXINE SODIUM 112 MCG if it has been recalled
• Check your prescription label to see if you have any LEVOTHYROXINE SODIUM in the affected lot numbers and expiration dates.
• If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting www.fda.gov/medwatch/report.htm or calling 1-800-FDA-0178.

On 07/23/2025, ACCORD HEALTHCARE recalled LEVOTHYROXINE SODIUM 100 MCG due to Subpotent Drug: Assay below the approved specification. The U.S. Food and Drug Administration (FDA) has issued a Class II Recall of the affected medications.

More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.

The detailed information of the recalled product is listed below:

Recalled Drug: LEVOTHYROXINE SODIUM 100 MCG
NDC Number: 16729045117
Lot Number(s): D2300092, D2400722
Expiration Date(s): 12/31/2025, 03/31/2026

What you should do:

• Do not continue to use LEVOTHYROXINE SODIUM 100 MCG if it has been recalled
• Check your prescription label to see if you have any LEVOTHYROXINE SODIUM in the affected lot numbers and expiration dates.
• If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting www.fda.gov/medwatch/report.htm or calling 1-800-FDA-0178.

On 07/19/2025, GRANULES PHARMA recalled METOPROLOL SUCCINATE 25 MG due to Failed Dissolution Specifications: Product failed to meet dissolution acceptance criteria in the stability studies at the 6th month (25¿C/60% RH) long-term. The U.S. Food and Drug
Administration (FDA) has issued a Class II Recall of the affected medications.

More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.

The detailed information of the recalled product is listed below:

Recalled Drug: METOPROLOL SUCCINATE 25 MG
NDC Number: 70010078001
Lot Number(s): 1400008A
Expiration Date(s): 12/31/2025

What you should do:

• Do not continue to use METOPROLOL SUCCINATE 25 MG if it has been recalled
• Check your prescription label to see if you have any METOPROLOL SUCCINATE in the affected lot numbers and expiration dates.
• If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting www.fda.gov/medwatch/report.htm or calling 1-800-FDA-0178.

On 07/09/2025, FRANULES PHARMA recalled METOPROLOL SUCCINATE 25 MG due to Failed Dissolution Specifications: Product failed to meet dissolution acceptance criteria in the stability studies at the 6th month (25¿C/60% RH) long-term. The U.S. Food and Drug
Administration (FDA) has issued a Class II Recall of the affected medications.

More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.

The detailed information of the recalled product is listed below: 

Recalled Drug: METOPROLOL SUCCINATE 25 MG
NDC Number: 70010078005
Lot Number(s): 1400008B
Expiration Date(s): 12/31/2025

What you should do: 

• Do not continue to use METOPROLOL SUCCINATE 25 MG if it has been recalled
• Check your prescription label to see if you have any METOPROLOL SUCCINATE in the affected lot numbers and expiration dates.
• If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting www.fda.gov/medwatch/report.htm or calling 1-800-FDA-0178.

On 07/02/2025, TEVA PHARMACEUTICALS recalled METOCLOPRAMIDE HCL 10 MG due to the Presence of foreign tablets/capsules. The U.S. Food and Drug Administration (FDA) has issued a Class II Recall of the affected medications.

More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.

The detailed information of the recalled product is listed below:

Recalled Drug: METOCLOPRAMIDE HCL 10 MG
NDC Number: 00093220301
Lot Number(s): 5420094
Expiration Date(s): 09/30/2027

What you should do:

• Do not continue to use METOCLOPRAMIDE HCL 10 MG if it has been recalled
• Check your prescription label to see if you have any METOCLOPRAMIDE HCL in the affected lot numbers and expiration dates.
• If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting www.fda.gov/medwatch/report.htm or calling 1-800-FDA-0178.

On 07/02/2025, APOTEX CORP recalled KETOROLAC TROMETHAMINE 0.5 % due to Lack of Assurance of Sterility. The U.S. Food and Drug Administration (FDA) has issued a Class II Recall of the affected medications.

More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.

The detailed information of the recalled product is listed below: 

Recalled Drug: KETOROLAC TROMETHAMINE 0.5 %
NDC Number: 60505100302
Lot Number(s): TZ1236
Expiration Date(s): 11/30/2025

What you should do:

• Do not continue to use KETOROLAC TROMETHAMINE 0.5 % if it has been recalled
• Check your prescription label to see if you have any KETOROLAC TROMETHAMINE in the affected lot numbers and expiration dates.
• If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting www.fda.gov/medwatch/report.htm or calling 1-800-FDA-0178.

On 07/02/2025, APOTEX CORP recalled AZELASTINE HCL 0.05 % due to Lack of Assurance of Sterility. The U.S. Food and Drug Administration (FDA) has issued a Class II Recall of the affected medications.

More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.

The detailed information of the recalled product is listed below:

Recalled Drug: AZELASTINE HCL 0.05 %
NDC Number: 60505057804
Lot Number(s): VD1654
Expiration Date(s): 06/30/2027

What you should do:

• Do not continue to use AZELASTINE HCL 0.05 % if it has been recalled
• Check your prescription label to see if you have any AZELASTINE HCL in the affected lot numbers and expiration dates.
• If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting www.fda.gov/medwatch/report.htm or calling 1-800-FDA-0178.

On 05/28/2025, ASTTRAZENECA recalled AIRSUPRA 90-80 MCG due to Defective delivery system. The U.S. Food and Drug Administration (FDA) has issued a Class II Recall of the affected medications.

More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.

The detailed information of the recalled product is listed below:

Recalled Drug: AIRSUPRA 90-80 MCG
NDC Number: 00310908012
Lot Number(s): 6270044C00, 6270040D00, 6270034E00, 6270053C00, 6270045C00, 6270047C00, 6270056C00, 6270052C00, 6270063E00, 6270064C00, 6270071D00, 6270075D00, 6270075F00 and 6270107C00
Expiration Date(s): 10/2026, 11/30/2026, 12/31/2026 and 9/30/2027

What you should do:

• Do not continue to use AIRSUPRA 90-80 MCG if it has been recalled
• Check your prescription label to see if you have any AIRSUPRA in the affected lot numbers and expiration dates.
• If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting www.fda.gov/medwatch/report.htm or calling 1-800-FDA-0178.

On 06/04/2025, GLENMARK PHARMACEUTICAL recalled CARVEDILOL 3.125 MG due to CGMP Deviations; presence ‘N-Nitroso Carvedilol I’ Impurity above the recommended acceptable intake limit. The U.S. Food and Drug Administration (FDA) has issued a Class II Recall of the affected medications.

More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.

The detailed information of the recalled product is listed below:

Recalled Drug: CARVEDILOL 3.125 MG
NDC Number: 68462016201
Lot Number(s): 19231450, 19233345, 19234275 and 19240280
Expiration Date(s): Mar-25, Jul-25, Sep-25 and Dec-25

What you should do:

• Do not continue to use CARVEDILOL 3.125 MG if it has been recalled
• Check your prescription label to see if you have any CARVEDILOL in the affected lot numbers and expiration dates. 
• If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting www.fda.gov/medwatch/report.htm or calling 1-800-FDA-0178.

On 06/04/2025, GLENMARK PHARMACEUTICALS recalled CARVEDILOL 12.5 MG due to CGMP Deviations; presence ‘N-Nitroso Carvedilol I’ Impurity above the recommended acceptable intake limit. The U.S. Food and Drug Administration (FDA) has issued a Class II Recall of the affected medications.

More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.

The detailed information of the recalled product is listed below:

Recalled Drug: CARVEDILOL 12.5 MG
NDC Number: 68462016405
Lot Number(s): 19231899, 19231922, 19231927, 19231967, 19231979, 19232226, 19232234, 19232265, 1923227,19232758, 19232759, 19232762 and 19232788
Expiration Date(s): Apr-25, May-25 and Exp Jun-25

What you should do:

• Do not continue to use CARVEDILOL 12.5 MG if it has been recalled
• Check your prescription label to see if you have any CARVEDILOL in the affected lot numbers and expiration dates.
• If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting www.fda.gov/medwatch/report.htm or calling 1-800-FDA-0178.

On 06/04/2025, GLENMARK PHARMACEUTICALS recalled CARVEDILOL 25 MG due to CGMP Deviations; presence ‘N-Nitroso Carvedilol I’ Impurity above the recommended acceptable intake limit. The U.S. Food and Drug Administration (FDA) has issued a Class II Recall of the affected medications.

More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.

The detailed information of the recalled product is listed below:

Recalled Drug: CARVEDILOL 25 MG
NDC Number: 68462016505
Lot Number(s): 19231107, 19231114, 19231152 and 19234866
Expiration Date(s): Feb-25 and Jan-26

What you should do:

• Do not continue to use CARVEDILOL 25 MG if it has been recalled
• Check your prescription label to see if you have any CARVEDILOL in the affected lot numbers and expiration dates.
• If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting www.fda.gov/medwatch/report.htm or calling 1-800-FDA-0178.

On 06/04/2025, GLENMARK PHARMACEUTICALS recalled CARVEDILOL 3.125 MG due to CGMP Deviations; presence ‘N-Nitroso Carvedilol I’ Impurity above the recommended acceptable intake limit. The U.S. Food and Drug Administration (FDA) has issued a Class II Recall of the affected medications.

More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.

The detailed information of the recalled product is listed below:

Recalled Drug: CARVEDILOL 3.125 MG
NDC Number: 68462016205
Lot Number(s): 19231450, 19231464, 19231471, 19231493, 19232083, 19232103, 19232658, 19233328, 19233343, 19233344, 19233345, 19234275,19234843, 19235039, 19240280 and 19240296
Expiration Date(s): Mar-25, Apr-25, Jun-25, Jul-25, Sep-25, Nov-25 and Dec-25

What you should do:

• Do not continue to use CARVEDILOL 3.125 MG if it has been recalled
• Check your prescription label to see if you have any CARVEDILOL in the affected lot numbers and expiration dates.
• If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting www.fda.gov/medwatch/report.htm or calling 1-800-FDA-0178.

On 06/04/2025, GLENMARK PHARMACEUTICALS recalled CARVEDILOL 6.25 MG due to CGMP Deviations; presence ‘N-Nitroso Carvedilol I’ Impurity above the recommended acceptable intake limit. The U.S. Food and Drug Administration (FDA) has issued a Class II Recall of the affected medications.

More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.

The detailed information of the recalled product is listed below:

Recalled Drug: CARVEDILOL 6.25 MG
NDC Number: 68462016301
Lot Number(s): 19233369, 19234162 and 19240543
Expiration Date(s): Jul-25, Sep-25, and Jan-26

What you should do:

• Do not continue to use CARVEDILOL 6.25 MG if it has been recalled
• Check your prescription label to see if you have any CARVEDILOL in the affected lot numbers and expiration dates.
• If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting www.fda.gov/medwatch/report.htm or calling 1-800-FDA-0178.

On 06/04/2025, GLENMARK PHARMACEUTICALS recalled CARVEDILOL 6.25 MG due to CGMP Deviations; presence ‘N-Nitroso Carvedilol I’ Impurity above the recommended acceptable intake limit. The U.S. Food and Drug Administration (FDA) has issued a Class II Recall of the affected medications.

More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.

The detailed information of the recalled product is listed below:

Recalled Drug: CARVEDILOL 6.25 MG
NDC Number: 68462016305
Lot Number(s): 19231174, 19231199, 19231164, 19231517,19231527, 19231566, 19231568, 19231595, 19231618, 19231634, 19231638, 19231448, 19232043, 19232051, 19232064, 19232322, 19232324, 19232365, 19232380, 19232389, 19232736, 19232743, 19232746, 19232756, 19232757, 19233369, 19233371, 19233405, 19233416, 19234162, 19234183, 19234192, 19234204, 19234223, 19234243, 19234263, 19234165, 19234242, 19234743, 19234774, 19234993, 19240223, 19240203, 19240211, 19240214, 19240247, 19240249, 19240272, 19240319 and 19240543
Expiration Date(s): Feb-25, Mar-25, Apr-25, May-25, Jun-25, Jul-25, Sep-25, Nov-25, Dec-25 and Jan-26

What you should do:

• Do not continue to use CARVEDILOL 6.25 MG if it has been recalled
• Check your prescription label to see if you have any CARVEDILOL in the affected lot numbers and expiration dates.
• If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting www.fda.gov/medwatch/report.htm or calling 1-800-FDA-0178.

On 05/07/2025, ACCORD HEALTHCARE recalled LEVOTHYROXINE SODIUM 112 MCG due to Subpotent Drug. The U.S. Food and Drug Administration (FDA) has issued a Class II Recall of the affected medications.

More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.

The detailed information of the recalled product is listed below:

Recalled Drug: LEVOTHYROXINE SODIUM 112 MCG
NDC Number: 16729045215
Lot Number(s): D2400725
Expiration Date(s): 03/2026

What you should do:

• Do not continue to use LEVOTHYROXINE SODIUM 112 MCG if it has been recalled
• Check your prescription label to see if you have any LEVOTHYROXINE SODIUM in the affected lot numbers and expiration dates.
• If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting www.fda.gov/medwatch/report.htm or calling 1-800-FDA-0178.

On 05/07/2025, ACCORD HEALTHCARE recalled LEVOTHYROXINE SODIUM 88 MCG due to Subpotent Drug. The U.S. Food and Drug Administration (FDA) has issued a Class II Recall of the affected medications.

More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.

The detailed information of the recalled product is listed below:

Recalled Drug: LEVOTHYROXINE SODIUM 88 MCG
NDC Number: 16729045017
Lot Number(s): D2300044
Expiration Date(s): 12/2025

What you should do:

• Do not continue to use LEVOTHYROXINE SODIUM 88 MCG if it has been recalled
• Check your prescription label to see if you have any LEVOTHYROXINE SODIUM in the affected lot numbers and expiration dates.
• If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting www.fda.gov/medwatch/report.htm or calling 1-800-FDA-0178.

On 05/07/2025, ACCORD HEALTHCARE recalled LEVOTHYROXINE SODIUM 50 MCG due to Subpotent Drug. The U.S. Food and Drug Administration (FDA) has issued a Class II Recall of the affected medications.

More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.

The detailed information of the recalled product is listed below:

Recalled Drug: LEVOTHYROXINE SODIUM 50 MCG
NDC Number: 16729044817
Lot Number(s): D2400547
Expiration Date(s): 02/2026

What you should do:

• Do not continue to use LEVOTHYROXINE SODIUM 50 MCG if it has been recalled
• Check your prescription label to see if you have any LEVOTHYROXINE SODIUM in the affected lot numbers and expiration dates.
• If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting www.fda.gov/medwatch/report.htm or calling 1-800-FDA-0178.

On 05/07/2025, ACCORD HEALTHCARE recalled LEVOTHYROXINE SODIUM 25 MCG due to Subpotent Drug. The U.S. Food and Drug Administration (FDA) has issued a Class II Recall of the affected medications.

More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.

The detailed information of the recalled product is listed below: 

Recalled Drug: LEVOTHYROXINE SODIUM 25 MCG
NDC Number: 16729044717
Lot Number(s): D2300323
Expiration Date(s): 01/2026

What you should do:

• Do not continue to use LEVOTHYROXINE SODIUM 25 MCG if it has been recalled
• Check your prescription label to see if you have any LEVOTHYROXINE SODIUM in the affected lot numbers and expiration dates.
• If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting www.fda.gov/medwatch/report.htm or calling 1-800-FDA-0178.

On 04/16/2025, Glenmark Pharmaceuticals recalled CARVEDILOL 12.5 MG due to CGMP Deviations. The U.S. Food and Drug Administration (FDA) has issued a Class II Recall of the affected medications.

More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.

The detailed information of the recalled product is listed below:

Recalled Drug: CARVEDILOL 12.5 MG
NDC Number: 68462016405
Lot Number(s): 17240238, 17240243, 17240245 and 17240248
Expiration Date(s): Jan-26, Jan-26, Jan-26 and Jan-26

What you should do:

• Do not continue to use CARVEDILOL 12.5 MG if it has been recalled
• Check your prescription label to see if you have any CARVEDILOL 12.5 MG in the affected lot numbers and expiration dates.
• If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting www.fda.gov/medwatch/report.htm or calling 1-800-FDA-0178.

On 04/16/2025, Somerset Therapeutics recalled HALOPERIDOL DECANOATE 50 MG/ML due to Lack of Assurance of Sterility: Media fill with bacterial contamination. The U.S. Food and Drug Administration (FDA) has issued a Class II Recall of the affected medications.

More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.

The detailed information of the recalled product is listed below:

Recalled Drug: HALOPERIDOL DECANOATE 50 MG/ML
NDC Number: 70069038110
Lot Number(s): A240467C
Expiration Date(s): 07/2026

What you should do:

• Do not continue to use HALOPERIDOL DECANOATE 50 MG/ML if it has been recalled
• Check your prescription label to see if you have any HALOPERIDOL DECANOATE 50 MG/ML in the affected lot numbers and expiration dates.
• If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting www.fda.gov/medwatch/report.htm or calling 1-800-FDA-0178.

On 04/16/2025, Glenmark Pharmaceuticals recalled INDOMETHACIN ER 75 MG due to CGMP Deviations. The U.S. Food and Drug Administration (FDA) has issued a Class II Recall of the affected medications.

More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.

The detailed information of the recalled product is listed below:

Recalled Drug: INDOMETHACIN ER 75 MG
NDC Number: 68462032560
Lot Number(s): 17232323, 17232335 and 17232323
Expiration Date(s): Oct-25, Oct-25 and Oct-25

What you should do:

• Do not continue to use INDOMETHACIN ER 75 MG if it has been recalled
• Check your prescription label to see if you have any INDOMETHACIN ER 75 MG in the affected lot numbers and expiration dates.
• If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting www.fda.gov/medwatch/report.htm or calling 1-800-FDA-0178.

On 04/16/2025, Glenmark Pharmaceuticals recalled LACOSAMIDE 100 MG due to CGMP Deviations. The U.S. Food and Drug Administration (FDA) has issued a Class II Recall of the affected medications.

More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.

The detailed information of the recalled product is listed below:

Recalled Drug: LACOSAMIDE 100 MG
NDC Number: 68462067960
Lot Number(s): 17232533, 17232534, 17240606, 17240619, 17240911, 17240912, 17241121 and 17241124
Expiration Date(s): Nov-25, Nov-25, Mar-26, Mar-26, May-26, May-26, Jun-26 and Jun-26

What you should do:

• Do not continue to use LACOSAMIDE 100 MG if it has been recalled
• Check your prescription label to see if you have any LACOSAMIDE 100 MG in the affected lot numbers and expiration dates.
• If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting www.fda.gov/medwatch/report.htm or calling 1-800-FDA-0178.

On 04/16/2025, Glenmark Pharmaceuticals recalled LACOSAMIDE 200 MG due to CGMP Deviations. The U.S. Food and Drug Administration (FDA) has issued a Class II Recall of the affected medications.

More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.

The detailed information of the recalled product is listed below:

Recalled Drug: LACOSAMIDE 200 MG
NDC Number: 68462068160
Lot Number(s): 17230982, 17230986, 17231001, 17240197, 17240198, 17240215, 17240846 and 17240847
Expiration Date(s): Apr-25, Apr-25, Apr-25, Jan-26, Jan-26, Jan-26, Apr-26 and Apr-26

What you should do:

• Do not continue to use LACOSAMIDE 200 MG if it has been recalled
• Check your prescription label to see if you have any LACOSAMIDE 200 MG in the affected lot numbers and expiration dates.
• If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting www.fda.gov/medwatch/report.htm or calling 1-800-FDA-0178.

On 04/16/2025, Glenmark Pharmaceuticals recalled NITROGLYCERIN 0.3 MG due to CGMP Deviations. The U.S. Food and Drug Administration (FDA) has issued a Class II Recall of the affected medications.

More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.

The detailed information of the recalled product is listed below:

Recalled Drug: NITROGLYCERIN 0.3 MG
NDC Number: 68462063801
Lot Number(s): 1723236 and 17232367
Expiration Date(s): Nov-25 and Nov-25

What you should do:

• Do not continue to use NITROGLYCERIN 0.3 MG if it has been recalled
• Check your prescription label to see if you have any NITROGLYCERIN 0.3 MG in the affected lot numbers and expiration dates.
• If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting www.fda.gov/medwatch/report.htm or calling 1-800-FDA-0178.

On 04/16/2025, Glenmark Pharmaceuticals recalled NITROGLYCERIN 0.4 MG due to CGMP Deviations. The U.S. Food and Drug Administration (FDA) has issued a Class II Recall of the affected medications.

More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.

The detailed information of the recalled product is listed below:

Recalled Drug: NITROGLYCERIN 0.4 MG
NDC Number: 68462063945
Lot Number(s): 17232024, 17232071 and 17232072
Expiration Date(s): Aug-25, Sep-25 and Sep-25

What you should do:

• Do not continue to use NITROGLYCERIN 0.4 MG if it has been recalled
• Check your prescription label to see if you have any NITROGLYCERIN 0.4 MG in the affected lot numbers and expiration dates.
• If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting www.fda.gov/medwatch/report.htm or calling 1-800-FDA-0178.

On 04/16/2025, Glenmark Pharmaceuticals recalled GABAPENTIN 600 MG due to CGMP Deviations. The U.S. Food and Drug Administration (FDA) has issued a Class II Recall of the affected medications.

More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.

The detailed information of the recalled product is listed below:

Recalled Drug: GABAPENTIN 600 MG
NDC Number: 68462012605
Lot Number(s): 17231015, 17231128, 17231138, 17231139, 17231143, 17231144, 17231848, 17231898, 17231977, 17231978, 17232015, 17232016, 17232017, 17232034, 17232041, 17232396, 17232406, 17232410, 17232490, 17240326, 17240327, 17240383, 17240395, 17241863, 17241869, 17241870, 17231256, 17231386, 17231387, 17231407, 17231417, 17231418, 17231754, 17240085, 17240117 and 17240131
Expiration Date(s): Apr-25, Apr-25, Apr-25, Apr-25, Apr-25, Apr-25, Aug-25, Aug-25, Aug-25, Aug-25, Aug-25, Aug-25, Aug-25, Aug-25, Aug-25, Nov-25, Nov-25, Nov-25, Nov-25, Jan-26, Jan-26, Feb-26, Feb-26, Oct-26, Oct-26, Oct-26, May-25, May-25, May-25, May-25, May-25, May-25, May-25, Jul-25, Dec-25 and Dec-25

What you should do:

• Do not continue to use GABAPENTIN 600 MG if it has been recalled
• Check your prescription label to see if you have any GABAPENTIN 600 MG in the affected lot numbers and expiration dates.
• If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting www.fda.gov/medwatch/report.htm or calling 1-800-FDA-0178.

On 04/16/2025, Glenmark Pharmaceuticals recalled PRAVASTATIN SODIUM 20 MG due to CGMP Deviations. The U.S. Food and Drug Administration (FDA) has issued a Class II Recall of the affected medications.

More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.

The detailed information of the recalled product is listed below:

Recalled Drug: PRAVASTATIN SODIUM 20 MG
NDC Number: 68462019605
Lot Number(s): 17230810, 17230811, 17230810, 17232501 and 17232502
Expiration Date(s): Mar-26, Mar-26, Mar-26, Nov-26 and Nov-26

What you should do:

• Do not continue to use PRAVASTATIN SODIUM 20 MG if it has been recalled
• Check your prescription label to see if you have any PRAVASTATIN SODIUM 20 MG in the affected lot numbers and expiration dates.
• If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting www.fda.gov/medwatch/report.htm or calling 1-800-FDA-0178.

On 04/16/2025, GLENMARK PHARMACEUTICALS, recalled SOLIFENACIN SUCCINATE 5 MG due to CGMP Deviations. The U.S. Food and Drug Administration (FDA) has issued a Class II Recall of the affected medications.

More information about the recall is at: http://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.

The detailed information of the recalled product is listed below:

Recalled Drug: SOLIFENACIN SUCCINATE 5 MG
NDC Number: 68462038630
Lot Number(s): 17232395, 17232400 and 17232395.
Expiration Date(s): Nov-25, Nov-25 and Nov-25.

What you should do:

• Do not continue to use SOLIFENACIN SUCCINATE 5 MG if it has been recalled
• Check your prescription label to see if you have any SOLIFENACIN SUCCINATE in the affected lot numbers and expiration dates.
• If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting www.fda.gov/medwatch/report.htm or calling 1-800-FDA-0178.

On 04/16/2025, GLENMARK PHARMACEUTICALS, recalled SOLIFENACIN SUCCINATE 10 MG due to CGMP Deviations. The U.S. Food and Drug Administration (FDA) has issued a Class II Recall of the affected medications.

More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.

The detailed information of the recalled product is listed below:

Recalled Drug: SOLIFENACIN SUCCINATE 10 MG
NDC Number: 68462038730
Lot Number(s): 17230762
Expiration Date(s): Mar-25

What you should do:

• Do not continue to use SOLIFENACIN SUCCINATE 10 MG if it has been recalled
• Check your prescription label to see if you have any SOLIFENACIN SUCCINATE in the affected lot numbers and expiration dates.
• If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting www.fda.gov/medwatch/report.htm or calling 1-800-FDA-0178.

On 04/16/2025, GLENMARK PHARMACEUTICALS, recalled SAXAGLIPTIN HCL 5 MG due to CGMP Deviations. The U.S. Food and Drug Administration (FDA) has issued a Class II Recall of the affected medications.

More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.

The detailed information of the recalled product is listed below:

Recalled Drug: SAXAGLIPTIN HCL 5 MG
NDC Number: 68462072790
Lot Number(s): 17232460, 17232460, 17241194 and 17241194.
Expiration Date(s): Nov-25, Nov-25, Jun-26 and Jun-26.

What you should do:

• Do not continue to use SAXAGLIPTIN HCL 5 MG if it has been recalled
• Check your prescription label to see if you have any SAXAGLIPTIN HCL in the affected lot numbers and expiration dates.
• If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting
  www.fda.gov/medwatch/report.htm or calling 1-800-FDA-0178.

On 04/16/2025, GLENMARK PHARMACEUTICALS, recalled SAXAGLIPTIN HCL 5 MG due to CGMP Deviations. The U.S. Food and Drug Administration (FDA) has issued a Class II Recall of the affected medications.
More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.

The detailed information of the recalled product is listed below:

Recalled Drug: SAXAGLIPTIN HCL 5 MG
NDC Number: 68462072730
Lot Number(s): 17232460, 17232460, 17241194 and 17241194.
Expiration Date(s): Nov-25, Nov-25, Jun-26 and Jun-26.

What you should do:

• Do not continue to use SAXAGLIPTIN HCL 5 MG if it has been recalled.
• Check your prescription label to see if you have any SAXAGLIPTIN HCL in the affected lot numbers and expiration dates.
• If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting www.fda.gov/medwatch/report.htm or calling 1-800-FDA-0178.

On 04/16/2025, GLENMARK PHARMACEUTICALS, recalled ROSUVASTATIN CALCIUM 40 MG due to CGMP Deviations. The U.S. Food and Drug Administration (FDA) has issued a Class II Recall of the affected medications.
More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.

The detailed information of the recalled product is listed below:

Recalled Drug: ROSUVASTATIN CALCIUM 40 MG
NDC Number: 68462026430
Lot Number(s): 17240389, 17240390, 17240426, 17240427, 17240428, 17240778, 17241055, 17241074, 17241075, 17241091 and 17241100.
Expiration Date(s): Feb-26, Feb-26, Feb-26, Feb-26, Feb-26, Apr-26, May-26, Jun-26, Jun-26, Jun-26 and Jun-26.

What you should do:

• Do not continue to use ROSUVASTATIN CALCIUM 40 MG if it has been recalled
• Check your prescription label to see if you have any ROSUVASTATIN CALCIUM in the affected lot numbers and expiration dates.
• If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting www.fda.gov/medwatch/report.htm or calling 1-800-FDA-0178.

On 04/16/2025, NORTHSTAR RX LLC, recalled PRAVASTATIN SODIUM 80 MG due to CGMP Deviations. The U.S. Food and Drug Administration (FDA) has issued a Class II Recall of the affected medications.

More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.

The detailed information of the recalled product is listed below:

Recalled Drug: PRAVASTATIN SODIUM 80 MG
NDC Number: 16714057001
Lot Number(s): 17221770, 17221774, 17231251, 17231262, 17232112 and 17232133.
Expiration Date(s): Aug-25, Aug-25, May-26, May-26, Sep-26 and Sep-26.

What you should do:

• Do not continue to use PRAVASTATIN SODIUM 80 MG if it has been recalled
• Check your prescription label to see if you have any PRAVASTATIN SODIUM in the affected lot numbers and expiration dates.
• If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting www.fda.gov/medwatch/report.htm or calling 1-800-FDA-0178.

On 04/19/2025, Northstar Rx LLC, recalled PRAVASTATIN SODIUM 20 MG due to CGMP deviations. The U.S. Food and Drug Administration (FDA) has issued a Class II Recall of the affected medications.
More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.

The detailed information of the recalled product is listed below:

Recalled Drug: PRAVASTATIN SODIUM 20 MG
NDC Number: 16714055901
Lot Number(s): 17230810
Expiration Date(s): Mar-26

What you should do:

• Do not continue to use PRAVASTATIN SODIUM 20 MG if it has been recalled
• Check your prescription label to see if you have any PRAVASTATIN SODIUM in the affected lot numbers and expiration dates.
• If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting www.fda.gov/medwatch/report.htm or calling 1-800-FDA-0178.

On 04/02/2025, Strides Pharma INC recalled TESTOSTERONE 25MG(1%) due to the Presence of foreign substance: Presence of Benzene. The U.S. Food and Drug Administration (FDA) has issued a Class II Recall of the affected medications. 

More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.

The detailed information of the recalled product is listed below:

Recalled Drug: TESTOSTERONE 25MG(1%)
NDC Number: 64380015102
Lot Number(s): 5501127A, 5501236A, 5501341A, 5501406A, 5501408A, 5501516A, 5501568A, 5501829A, 5502000A, 5502004A, 5502005A, 5502092A, 5502217A and 5502262A
Expiration Date(s): Apr-25, Jun-25, Jul-25, Aug-25, Sep-25, Oct-25, Mar-26, Jul-26, Aug-26, Oct-26, Dec-26 and Jan-27

What you should do:

• Do not continue to use TESTOSTERONE 25MG(1%) if it has been recalled
• Check your prescription label to see if you have any TESTOSTERONE in the affected lot numbers and expiration dates. 
• If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting www.fda.gov/medwatch/report.htm or calling 1-800-FDA-0178.

On 04/02/2025, Strides Pharma, INC recalled TESTOSTERONE 50 MG (1%) due to the Presence of foreign substance: Presence of Benzene. The U.S. Food and Drug Administration (FDA) has issued a Class II Recall of the affected medications.

More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.

The detailed information of the recalled product is listed below:

Recalled Drug: TESTOSTERONE 50 MG (1%)
NDC Number: 64380015202
Lot Number(s): 5501103A, 5501237A, 5501238A, 5501278A, 5501280A, 5501342A, 5501372A, 5501496A, 5501499A, 5501580A, 5501582A, 5501653A, 5501656A, 5501770A, 5501842A, 5501868A, 5501882A, 5501957A, 5502001A, 5502033A, 5502112A, 5502115A, 5502180A and 5502181A
Expiration Date(s): Mar-25, Apr-25, May-25, Jun-25, Jul-25, Aug-25, Sep-25, Oct-25, Dec-25, Jan-26, Feb-26, Apr-26, May-26, Jul-26, Aug-26, Oct-26 and Nov-26.

What you should do:

• Do not continue to use TESTOSTERONE 50 MG (1%) if it has been recalled
•  Check your prescription label to see if you have any TESTOSTERONE in the affected lot numbers and expiration dates.
• If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting www.fda.gov/medwatch/report.htm or calling 1-800-FDA-0178.

On 03/12/2025 Safecor Health, LLC recalled MORPHINE SULFATE 100 MG/5ML due to Defective Delivery System: Leakage observed after oral solution was repackaged into unitdose syringes. The U.S. Food and Drug Administration (FDA) has issued a Class II Recall of the affected medications.

More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.

The detailed information of the recalled product is listed below:

Recalled Drug: MORPHINE SULFATE 100 MG/5ML
NDC Number: 00406800312
Lot Number(s): 24220672, 24280145 and 24240711
Expiration Date(s): 02/19/2025, 03/18/2025 and 03/19/2025

What you should do:

• Do not continue to use MORPHINE SULFATE 100 MG/5ML if it has been recalled
• Check your prescription label to see if you have any MORPHINE SULFATE in the affected lot numbers and expiration dates.
• If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting www.fda.gov/medwatch/report.htm or calling 1-800-FDA-0178.

On 03/12/2025 Safecor Health, LLC recalled LORAZEPAM 2 MG/ML due to Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes. The U.S. Food and Drug Administration (FDA) has issued a Class II Recall of the affected medications.

More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.

The detailed information of the recalled product is listed below:

Recalled Drug: LORAZEPAM 2 MG/ML
NDC Number: 00121077001
Lot Number(s): 24251067 and 24421733
Expiration Date(s): 03/25/2025 and 06/03/2025

What you should do:

• Do not continue to use LORAZEPAM 2 MG/ML if it has been recalled
• Check your prescription label to see if you have any LORAZEPAM in the affected lot numbers and expiration dates.
• If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting www.fda.gov/medwatch/report.htm or calling 1-800-FDA-0178.

On 03/12/2025, Safecor Health recalled LORAZEPAM INTENSOL 2 MG/ML due to Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes. The U.S. Food and Drug Administration (FDA) has issued a Class II Recall of the affected medications.

More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.

The detailed information of the recalled product is listed below:

Recalled Drug: LORAZEPAM INTENSOL 2 MG/ML
NDC Number: 00054353244
Lot Number(s): 24210274 and 24401700
Expiration Date(s): 01/31/2025 and 04/25/2025

What you should do:

• Do not continue to use LORAZEPAM INTENSOL 2 MG/ML if it has been recalled
• Check your prescription label to see if you have any LORAZEPAM INTENSOL in the affected lot numbers and expiration dates.
• If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting www.fda.gov/medwatch/report.htm or calling 1-800-FDA-0178.

On 02/26/2025, Alvogen, INC recalled FENTANYL 25 MCG/HR due to Defective delivery system – patches could be multi-stacked, adhered one on top of the other, in a single product pouch. The U.S. Food and Drug Administration (FDA) has issued a Class I Recall
of the affected medications.

More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.

The detailed information of the recalled product is listed below:

Recalled Drug: FENTANYL 25 MCG/HR
NDC Number: 47781042447
Lot Number(s): 108319
Expiration Date(s): 04/30/2027

What you should do: 

• Do not continue to use FENTANYL 25 MCG/HR if it has been recalled
• Check your prescription label to see if you have any FENTANYL in the affected lot numbers and expiration dates.
• If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting www.fda.gov/medwatch/report.htm or calling 1-800-FDA-0178.

On 02/26/2025, Major Pharmaceuticals recalled LORAZEPAM 1 MG due to Failed impurities/degradation specifications and Sub-potent Drug: Out-of-specification results were obtained during routine stability testing for Assay and Impurities. The U.S. Food and Drug Administration (FDA) has issued a Class II Recall of the affected medications.

More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.

The detailed information of the recalled product is listed below:

Recalled Drug: LORAZEPAM 1 MG
NDC Number: 00904600861
Lot Number(s): N01419, N01420, N01421, N01663, N01664, N01673, N01688, N01747, N01748, N01749, N01792, N01857, N01974 and N02081.
Expiration Date(s): 03/31/2025, 06/30/2025, 08/31/2025, 09/30/2025, 08/31/2025, 11/30/2025, 12/31/2025, 02/28/2026, 05/31/2026 and 08/31/2026

What you should do:

• Do not continue to use LORAZEPAM 1 MG if it has been recalled
• Check your prescription label to see if you have any LORAZEPAM in the affected lot numbers and expiration dates.
• If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting www.fda.gov/medwatch/report.htm or calling 1-800-FDA-0178.

On 1/15/2025, ENDO USA, INC recalled CLONAZEPAM 0.125 MG ODT TABLET due to Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength. The U.S. Food and Drug Administration (FDA) has issued a Class I Recall of the affected medications.

More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.

The detailed information of the recalled product is listed below:

Recalled Drug: CLONAZEPAM 0.125 MG ODT TABLET
NDC Number: 49884030602
Lot Number(s): 550174101
Expiration Date(s): 1/31/2024

What you should do:

• Do not continue to use CLONAZEPAM 0.125 MG ODT TABLET if it has been recalled
• Check your prescription label to see if you have any CLONAZEPAM in the affected lot numbers and expiration dates.
• If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting www.fda.gov/medwatch/report.htm or calling 1-800-FDA-0178.

On 1/15/2025 ENDO USA, INC recalled CLONAZEPAM 0.25 MG ODT TABLET due to Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength. The U.S. Food and Drug Administration (FDA) has issued a Class I Recall of the affected medications.

More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.

The detailed information of the recalled product is listed below:

Recalled Drug: CLONAZEPAM 0.25 MG ODT TABLET
NDC Number: 49884030702
Lot Number(s): 550142801, 550142901, 550143001, 550143101, 550143201, 550143301, 550143401, 550147201 AND 550147401
Expiration Date(s): 08/31/2026

What you should do:

• Do not continue to use CLONAZEPAM 0.25 MG ODT TABLET if it has been recalled
• Check your prescription label to see if you have any CLONAZEPAM in the affected lot numbers and expiration dates.
• If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting www.fda.gov/medwatch/report.htm or calling 1-800-FDA-0178.

On 1/15/2025, ENDO USA, INC recalled CLONAZEPAM 1 MG ODT TABLET due to Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength. The U.S. Food and Drug Administration (FDA) has issued a Class I Recall of the affected medications.

More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.

The detailed information of the recalled product is listed below:

Recalled Drug: CLONAZEPAM 1 MG ODT TABLET
NDC Number: 49884030902
Lot Number(s): 550145201, 550175901, 550176001 AND 550176201
Expiration Date(s): 08/31/2026 AND 02/28/2027

What you should do:

• Do not continue to use CLONAZEPAM 1 MG ODT TABLET if it has been recalled
• Check your prescription label to see if you have any CLONAZEPAM in the affected lot numbers and expiration dates.
• If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting www.fda.gov/medwatch/report.htm or calling 1-800-FDA-0178.

On 1/15/2025, ENDO USA, INC recalled CLONAZEPAM 2 MG ODT TABLET due to Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength. The U.S. Food and Drug Administration (FDA) has issued a Class I Recall of the affected medications.

More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.

The detailed information of the recalled product is listed below:

Recalled Drug: CLONAZEPAM 2 MG ODT TABLET
NDC Number: 49884031002
Lot Number(s): 550176501 AND 550176601
Expiration Date(s): 02/28/2027

What you should do:

• Do not continue to use CLONAZEPAM 2 MG ODT TABLET if it has been recalled
• Check your prescription label to see if you have any CLONAZEPAM in the affected lot numbers and expiration dates.
• If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting www.fda.gov/medwatch/report.htm or calling 1-800-FDA-0178.

On 01/08/2025, Lupin Pharmaceuticals recalled LEVOTHYROXINE SODIUM 75 MCG due to Failed Impurities/Degradation Specifications: Out of specifications result observed in the drug substance for impurity test during 3-month long term stability study. The U.S. Food and Drug
Administration (FDA) has issued a Class II Recall of the affected medications.

More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.

The detailed information of the recalled product is listed below:

Recalled Drug: LEVOTHYROXINE SODIUM 75 MCG
NDC Number: 68180096703
Lot Number(s): LA01276
Expiration Date(s): 07/2026

What you should do:

• Do not continue to use LEVOTHYROXINE SODIUM 75 MCG if it has been recalled
• Check your prescription label to see if you have any LEVOTHYROXINE SODIUM in the affected lot numbers and expiration dates.
• If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting www.fda.gov/medwatch/report.htm or calling 1-800-FDA-0178.